Harriet M. Kluger

Also affiliated with Yale University, University of New Haven, Smilow Cancer Hospital

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 68 papers. Top paper: “Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial”.

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30111-x

N/A

6.6DataRank · unranked

541 citations

Kurt A. Schalper, Scott Gettinger, Amit Mahajan, Roy S. Herbst, Anne C. Chiang +19 more

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Molecular Cancer(2023)10.1186/s12943-023-01884-x

N/A

0.635DataRank · unranked

14 citations

Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi +18 more

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma

JCI Insight(2024)10.1172/jci.insight.184545

N/A

0.466DataRank · unranked

14 citations

Dijana Djureinovic, David Su, Lin Zhang, Benjamin Y. Lu, Larisa Kamga +8 more

Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma

Nature Immunology(2024)10.1038/s41590-024-02023-4

N/A

0.461DataRank · unranked

10 citations

Liliana E. Lucca, Wesley Lewis, Jiping Wang, Catarina V. Nogueira, Sebastian Heer +22 more

SIMVI reveals intrinsic and spatial-induced states in spatial omics data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.28.554970

N/A

0.292DataRank · unranked

5 citations

David Su, Harriet M. Kluger, Rong Fan, Yuval Kluger, Mingze Dong

A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3158

N/A

0DataRank · unranked

6 citations

María E. Suarez‐Almazor, Jeane Painter, Tanner M. Johanns, Michael Dougan, Laura C. Cappelli +15 more

Circulating Clonally Expanded T Cells Reflect Functions of Tumor Infiltrating T Cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.321240

N/A

0DataRank · unranked

4 citations

Pierre‐Paul Axisa, Benjamin Y. Lu, Brian Harnett, Shlomit Jessel, Le Zhang +8 more

Ablation of Histone Demethylase KDM5B in Melanoma Augments Anti-Tumor Immunity through Upregulation of Retroelements

Research Square(2020)10.21203/rs.3.rs-87705/v1

N/A

0DataRank · unranked

0 citations

Wesley L. Cai, Xiaoni Liu, Durga Thakral, Goran Micevic, Carmen J. Booth +10 more

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

Science(2021)10.1126/science.aba2609

N/A

0DataRank · unranked

206 citations

Nicolás A. Giraldo, Benjamin Green, Tricia R. Cottrell, Julie E. Stein, Elizabeth L. Engle +32 more

Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.053

N/A

0DataRank · unranked

150 citations

Haixiang Su, Caroline H. Johnson, Sajid Khan, Harriet M. Kluger, Lingeng Lu +1 more

Agonistic CD40 Antibodies in Cancer Treatment

Cancers(2021)10.3390/cancers13061302

N/A

0DataRank · unranked

106 citations

Meina Wang, Harriet M. Kluger, Dijana Djureinovic

Adverse events induced by immune checkpoint inhibitors

Current Opinion in Immunology(2021)10.1016/j.coi.2021.02.002

N/A

0DataRank · unranked

69 citations

Harriet M. Kluger, Kevan C. Herold, Ana Luisa Perdigoto

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Scientific Reports(2021)10.1038/s41598-021-82305-1

N/A

0DataRank · unranked

26 citations

Isabel D. Friesner, Emanuelle M. Rizk, Benjamin T. Fullerton, Manas Mondal, Megan H. Trager +24 more

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

Cancers(2021)10.3390/cancers13051049

N/A

0DataRank · unranked

14 citations

Chetan K. Rane, Christopher R. Zito, Sarah A. Weiss, Shlomit Jessel, Liliana E. Lucca +9 more

A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps2676

N/A

0DataRank · unranked

29 citations

Michael Dougan, Sarthak Gupta, Laura C. Cappelli, Tamiko R. Katsumoto, Osama E. Rahma +15 more

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function

Frontiers in Oncology(2022)10.3389/fonc.2022.836859

N/A

0DataRank · unranked

77 citations

Sarah A. Weiss, Matthew Austin, Amit Mahajan, Katrina Etts, Lin Zhang +7 more

TCR-sequencing in cancer and autoimmunity: barcodes and beyond

Trends in Immunology(2022)10.1016/j.it.2022.01.002

N/A

0DataRank · unranked

54 citations

Kaitlyn A. Lagattuta, Benjamin Y. Lu, Liliana E. Lucca, Adil Daud, David A. Hafler +4 more

Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes

JCI Insight(2022)10.1172/jci.insight.156330

N/A

0DataRank · unranked

51 citations

Songyan Deng, Katherine Du, Manik Kuchroo, Daniel B. Burkhardt, Alexander Tong +15 more

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004421

N/A

0DataRank · unranked

40 citations

Yu Yamamoto, Mark A. Perazella, Nazlı Dizman, Anushree C. Shirali, Navid Hafez +9 more

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

Frontiers in Oncology(2022)10.3389/fonc.2022.990367

N/A

0DataRank · unranked

20 citations

Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar +5 more

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13059

N/A

0DataRank · unranked

16 citations

Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire +22 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma

Cellular and Molecular Life Sciences(2022)10.1007/s00018-022-04364-5

N/A

0DataRank · unranked

13 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Olivia K. Provance +8 more

Inhibition of renalase drives tumour rejection by promoting T cell activation

European Journal of Cancer(2022)10.1016/j.ejca.2022.01.002

N/A

0DataRank · unranked

12 citations

Shlomit Jessel, Rihao Qu, Yuval Kluger, Tian-Min Chen, Lindsay Hollander +10 more

Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure

Molecular Cancer(2022)10.1186/s12943-022-01688-5

N/A

0DataRank · unranked

8 citations

Yuval Kluger, Junchen Yang, Jun Zhao, David A. Hafler, Diane S. Krause +6 more

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

npj Precision Oncology(2022)10.1038/s41698-022-00330-3

N/A

0DataRank · unranked

8 citations

Leonidas Salichos, Sandra Martínez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi +8 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of distant metastasis initiation in melanoma

Research Square(2022)10.21203/rs.3.rs-1244262/v1

N/A

0DataRank · unranked

0 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Thuy Tran +7 more

IL-7R licenses a population of epigenetically poised memory CD8 + T cells with superior antitumor efficacy that are critical for melanoma memory

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2304319120

N/A

0DataRank · unranked

49 citations

Andrew Daniels, Karine Flem‐Karlsen, Koonam Park, Ronan Talty, Meaghan K. McGeary +12 more

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma

JCI Insight(2023)10.1172/jci.insight.157347

N/A

0DataRank · unranked

39 citations

Jasmine I. Caulfield, Lin Zhang, David A. Schoenfeld, Dijana Djureinovic, Veronica Chiang +6 more

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006570

N/A

0DataRank · unranked

19 citations

Lilach Aizenbud, Ana Luisa Perdigoto, Eric Meffre, Lucia B. Jilaveanu, Dominika A. Michalek +7 more

Determinants of overall survival in patients with metastatic uveal melanoma

Cancer(2023)10.1002/cncr.34927

N/A

0DataRank · unranked

11 citations

Renelle Pointdujour‐Lim, Sofia Miguez, Yesung Lee, Bailey S.C.L. Jones, Christopher A. Barker +8 more

ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007358

N/A

0DataRank · unranked

11 citations

Liliana E. Lucca, Matthew R Austin, Ross D. Merkin, Marie E. Robert, Badr Al‐Bawardy +8 more

Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0215

N/A

0DataRank · unranked

10 citations

Daniel Y. Lee, Min Ding, Sandra Martínez-Morilla, Thazin Nwe Aung, Feriel Ouerghi +8 more

Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care

Pigment Cell & Melanoma Research(2023)10.1111/pcmr.13116

N/A

0DataRank · unranked

8 citations

Adrienne Boire, Priscilla K. Brastianos, Harriet M. Kluger, Eva Hernando‐Monge, Peter Forsyth +6 more

Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma

Ophthalmology(2023)10.1016/j.ophtha.2023.01.020

N/A

0DataRank · unranked

7 citations

R. Lee, Alison Chan, Patrick Demkowicz, Bailey S.C.L. Jones, Christopher P. Long +9 more

Peripheral blood immune cell and cytokine profiling of patients receiving corticosteroids for immune checkpoint inhibitor-related adverse events: Steroid dose and duration.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14694

N/A

0DataRank · unranked

2 citations

David A. Schoenfeld, Dijana Djureinovic, Matthew Austin, Mamie Wang, Rihao Qu +8 more

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma

Research Square(2023)10.21203/rs.3.rs-3314825/v1

N/A

0DataRank · unranked

2 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

Data from Genomic Heterogeneity and the Small Renal Mass

(2023)10.1158/1078-0432.c.6527436.v1

N/A

0DataRank · unranked

0 citations

Zuoquan Xie, Marta Boeke, Jamil Syed, Kevin Nguyen, Patrick D. McGillivray +8 more

Data from Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer

(2023)10.1158/1078-0432.c.6517146

N/A

0DataRank · unranked

0 citations

Robert L. Camp, Candice Schwartz, David L. Rimm, Harriet M. Kluger, Yuval Kluger +1 more

Data from C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas

(2023)10.1158/1078-0432.c.6517974

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Saadia A. Aziz, Patricia J. Conrad, John C. Schmitz, Mario Sznol +4 more

Data from A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1

(2023)10.1158/1078-0432.c.6530444

N/A

0DataRank · unranked

0 citations

Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia B. Jilaveanu +17 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846.v1

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

Subsets of interferon signaling and response to immune checkpoint blockade.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9522

N/A

0DataRank · unranked

0 citations

Brooke Horowitch, Min Ding, Sandra Martínez-Morilla, Thazin Nwe Aung, Feriel Ouerghi +8 more

Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007397

N/A

0DataRank · unranked

0 citations

David A. Schoenfeld, Jasmine I. Caulfield, Jacqueline E. Mann, Matthew R Austin, Ana Luisa Perdigoto +3 more

Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3932

N/A

0DataRank · unranked

17 citations

Jonathan Warrell, Sandra Martínez-Morilla, Niki Gavrielatou, Ioannis Vathiotis, Vesal Yaghoobi +4 more

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma

JCO Precision Oncology(2024)10.1200/po.23.00702

N/A

0DataRank · unranked

12 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

GP100 expression is variable in intensity in melanoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03776-5

N/A

0DataRank · unranked

10 citations

Nitzan Hasson, David Su, Adebowale Adeniran, Keiran S.M. Smalley, Dijana Djureinovic +4 more

Patterns of brain metastases response to immunotherapy with pembrolizumab

Journal of Neuro-Oncology(2024)10.1007/s11060-024-04754-8

N/A

0DataRank · unranked

5 citations

Sarah Goldberg, Sarah A. Weiss, Thuy Tran, Kanwar Pal Singh, Kavita Joshi +4 more

1102P Immune checkpoint inhibitor rechallenge after treatment with tumor-infiltrating lymphocytes in unresectable melanoma

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1170

N/A

0DataRank · unranked

4 citations

James W. Smithy, Christy Los, Hannah L. Kalvin, Nathan Hasson, R. Amaria +15 more

16S rRNA target sequencing of human tumors validates findings of Lachnoclostridium abundance in human melanomas that are heavily CD8+ T-cell infiltrated

European Journal of Cancer(2024)10.1016/j.ejca.2024.115084

N/A

0DataRank · unranked

2 citations

Caroline H. Johnson, Sajid Khan, Harriet M. Kluger, Lingeng Lu

TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03773-8

N/A

0DataRank · unranked

3 citations

Lucia B. Jilaveanu, Adebowale Adeniran, David Su, Michael E. Hurwitz, David A. Braun +3 more

Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100120

N/A

0DataRank · unranked

1 citations

Madeline McNamara, Margaret A. Kaszycki, Alexander E. Frey, Jeffrey J. Ishizuka, Philippos Apolinário Costa +6 more

Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma

Research Square(2024)10.21203/rs.3.rs-3956671/v1

N/A

0DataRank · unranked

0 citations

Benjamin Y. Lu, Liliana E. Lucca, Wesley Lewis, Jiping Wang, Catarina Nogeuira +20 more

Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.28.620093

N/A

0DataRank · unranked

0 citations

Gabriela A. Pizzurro, Alev Baysoy, Janani Baskaran, Ziyan Xu, Varsha Mathew +10 more

Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor–associated acute interstitial nephritis

Kidney International(2025)10.1016/j.kint.2025.05.029

N/A

0DataRank · unranked

13 citations

Kavita Mistry, Firasat M Alikhan, Sherley M. Mejia, Sagar Sadarangani, Andrew Cao +22 more

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012358

N/A

0DataRank · unranked

4 citations

Noam Savion‐Gaiger, Ana Luisa Perdigoto, Jacqueline E. Mann, Madeline Candelas Torres, Genevieve M. Boland +12 more

CTLA-4 blockade shifts the B cell repertoire toward autoimmunity

Journal of Clinical Investigation(2025)10.1172/jci189074

N/A

0DataRank · unranked

4 citations

Meng Wang, Yile Dai, Adrien Mirouse, Clarence Rachel Villanueva-Pachas, Delphine Bouis +14 more

Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients

Frontiers in Endocrinology(2025)10.3389/fendo.2025.1697724

N/A

0DataRank · unranked

2 citations

Michael E. Hurwitz, Navid Hafez, Harriet M. Kluger, Kevan C. Herold, Ana Luisa Perdigoto +1 more

Targeting an essential viral oncoprotein with an IL-7-enhanced mRNA vaccine induces durable immunity to Merkel cell carcinoma

Cell Reports(2025)10.1016/j.celrep.2025.116359

N/A

0DataRank · unranked

1 citations

Kathryn Clulo, Yuewei Fei, Therese Cordero Dumit, Frankie Scallo, Jerry William Allen +12 more

Microglial reprogramming: a potential new frontier in enhancing immunotherapy for melanoma brain metastasis

Molecular Oncology(2025)10.1002/1878-0261.70028

N/A

0DataRank · unranked

0 citations

Dorin Bar‐Ziv, Harriet M. Kluger, Noam Savion‐Gaiger

PRAME is not a frequently expressed antigen in renal cell carcinoma

BJUI Compass(2025)10.1002/bco2.70037

N/A

0DataRank · unranked

0 citations

Yael Derdikman Ofir, Jacqueline E. Mann, David Su, Tara Kim, Oscar Perales +5 more

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells

The Journal of Experimental Medicine(2020)10.1084/jem.20200921

N/A

0DataRank · unranked

88 citations

Pierre‐Paul Axisa, Benjamin Y. Lu, Brian Harnett, Shlomit Jessel, Le Zhang +8 more

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

Pigment Cell & Melanoma Research(2020)10.1111/pcmr.12861

N/A

0DataRank · unranked

56 citations

Keiran S.M. Smalley, Priscilla K. Brastianos, Michael A. Davies, Ian E. McCutcheon, James K. Liu +13 more

Neoadjuvant anti–programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series

JAAD Case Reports(2020)10.1016/j.jdcr.2020.05.010

N/A

0DataRank · unranked

13 citations

Jamie K. Hu, William Damsky, Kelly Olino, Harriet M. Kluger, James Clune +5 more

Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic

Infection Control and Hospital Epidemiology(2020)10.1017/ice.2020.337

N/A

0DataRank · unranked

43 citations

Yariv Aizenbud, Ariel Jaffe, Fabio Parisi, Lilach Aizenbud, Eyal Minsky-Fenick +5 more

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03619-0

N/A

0DataRank · unranked

27 citations

Christopher R. Zito, Thuy Tran, Kazuki Heishima, Veronique Neumeister, John J. McGuire +4 more